Interpretation and thinking of indicators of pharmaceutical administration in National Tertiary Public Hospitals Performance Evaluation Operational Manual （2022 edition）
- VernacularTitle:《国家三级公立医院绩效考核操作手册（2022版）》药事管理指标解读及思考
- Author:
Silu XU
1
;
Nan WU
1
;
Ning CAI
1
;
Min ZHAO
1
;
Jie PAN
2
;
Jifu WEI
1
Author Information
1. Dept. of Pharmacy，Jiangsu Cancer Hospital/ Jiangsu Institute of Cancer Research/the Affiliated Cancer Hospital of Nanjing Medical University，Nanjing 210009，China
2. Dept. of Pharmacy，the Second Affiliated Hospital of Soochow University，Jiangsu Suzhou 215004，China
- Publication Type:Journal Article
- Keywords:
tertiary public hospitals;
performance
- From:
China Pharmacy
2022;33(13):1541-1547
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To interpret the revision of the in dicators o f pharmaceutical administration in National Tertiary Public Hospitals Performance Evaluation Operational Manual （2022 edition）[hereinafter referred to as the Mannual（2022 edition）]，and to provide reference for the implementation of a new round of performance appraisal in tertiary public hospitals. METHODS The contents and revision details of the indicators of pharmaceutical administration in the Mannual（2022 edition）were described briefly，and the revised contents were interpreted and relevant suggestions were put forward. RESULTS & CONCLUSIONS The Manual（2022 edition）continued the scope of performance evaluation ，indicators’structure and sequence in the Manual（2020 edition），which focused on rational drug use and drug cost control. The Manual （2022 edition） placed more emphasis on strengthening the provision and use of essential medicines and selected drugs in the centralized drug procurement ，and further reducing the burden of medical costs in patients. It is suggested that tertiary public hospitals scientifically set indicators for the use of essential medicines ，selected drugs in the centralized drug procurement ，auxiliary drugs and antibacterial drugs in clinical departments，and improve relevant incentive mechanisms and performance assessment systems ；strengthen the interpretation of policies about essential medicines and drug centralized procurement ，as well as the training of rational drug use ；optimize in-hospital drug catalog and formulary ；formulate medication standards ，strengthen prescription review ，rational medication review and assessment ；establish and improve the drug use monitoring and evaluation and early warning system so as to standardize clinical drug use behavior by information technology ；strengthen the use of essential drugs and centrally purchase selected drugs on the basis of ensuring rationality ；control the unreasonable gradually reduce the increase in average drug costs.
